Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$65.71 -0.54 (-0.82%)
As of: Sep 30, 2026 · 2:54 PM EDT

Arrowhead Pharmaceuticals (ARWR) FCF Margin (2010 - 2026)

Updated

Arrowhead Pharmaceuticals' FCF Margin came in at -240.95% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 324.77 percentage points from -565.72% a year earlier but down 351.99 percentage points from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) FCF Margin (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Arrowhead Pharmaceuticals reported FCF Margin of -11.22%, down 8.15 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at 18.91%, up 17037.22 percentage points from FY2024.

  • FCF Margin carries a five-year change of +141.37 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, FCF Margin was -17018.30% in FY2024 (-16880.96 pp), -137.34% in FY2023 (-59.67 pp), -77.67% in FY2022 (-184.51 pp) and 106.84% in FY2021 (+229.30 pp).
  • The five-year range for quarterly FCF Margin is -6151.52% (fiscal Q1 2025) to 111.04% (fiscal Q2 2026).
  • Year-over-year, FCF Margin has increased for three consecutive quarters, with an average year-over-year change of +1402.06 percentage points over the last four quarters.
  • The fastest year-over-year change in FCF Margin over five years came in fiscal Q1 2026 (a gain of 6155.81 percentage points), and the weakest in fiscal Q1 2024 (a drop of 5068.98 percentage points).
  • Business Quant data shows ARWR's FCF Margin at 111.04% (Q2 2026), 4.29% (Q1 2026) and 5.06% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.82%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 18.33%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 26.96%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 43.05%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 34.72%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.70%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 30.39%
10 Arrowhead Pharmaceuticals 9.35 Bn 4.13 Bn - -240.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -240.95%
Mar 31, 2026 111.04%
Dec 31, 2025 4.29%
Sep 30, 2025 5.06%
Jun 30, 2025 -565.72%
Mar 31, 2025 83.79%
Dec 31, 2024 -6,151.52%
Dec 31, 2023 -5,251.93%
Sep 30, 2023 -558.07%
Jun 30, 2023 -425.79%
Mar 31, 2023 -40.33%
Dec 31, 2022 -182.95%
Sep 30, 2022 -321.29%
Jun 30, 2022 -241.73%
Mar 31, 2022 38.19%
Dec 31, 2021 -244.49%
Sep 30, 2021 -84.18%
Jun 30, 2021 -73.09%
Mar 31, 2021 782.38%
Dec 31, 2020 -202.76%
API Access

Arrowhead Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ARWR&period=max&api_key=YOUR_API_KEY